MedTrace Logo

Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction

NCT02749162 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-08-02

No results posted yet for this study

Summary

The effect of perineural dexamethasone administered as an adjuvant in prolonging the duration of analgesia continues to be under debate. The investigators performed a prospective randomized study to evaluate the effect of perineural dexamethasone in different concentrations in postoperative analgesia in femoral nerve block for anterior cruciate ligament reconstruction.

Conditions

  • Postoperative Pain

Interventions

DRUG

Dexamethasone phosphate

At the end of surgery the patients received single shot VIB block with the mixture according to the group allocation

DRUG

Paracetamol

After the block regression, at the first analgetic request the patients received the analgesia protocol

DRUG

Morphine

After the block regression, at the first analgetic request the patients received the analgesia protocol

DRUG

Lidocaine

At the end of surgery the patients received single shot VIB block with the mixture according to the group allocation

DRUG

Ropivacaine

At the end of surgery the patients received single shot VIB block with the mixture according to the group allocation

Sponsors & Collaborators

  • Foisor Orthopedics Clinical Hospital

    lead OTHER

Principal Investigators

  • Ioan Cristian Stoica, Prof · Foisor Orthopedics Clinical Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Romania

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02749162 on ClinicalTrials.gov